EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias.
OBJECTIVE
These EFNS guidelines on the molecular diagnosis of neurogenetic disorders are designed to provide practical help for the general neurologist to make appropriate use of molecular genetics in diagnosing neurogenetic disorders.


METHODS
Literature searches were performed before expert members of the task force wrote proposals, which were discussed in detail until final consensus had been reached among all task force members.


CONCLUSIONS
This paper provides updated guidelines for molecular diagnosis of two particularly complex groups of disorders, the ataxias and spastic paraplegias. Possibilities and limitations of molecular genetic diagnosis of these disorders are evaluated and recommendations are provided.
Gasser
T
T
Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. thomas.gasser@uni-tuebingen.de
Finsterer
J
J
Baets
J
J
Van Broeckhoven
C
C
Di Donato
S
S
Fontaine
B
B
De Jonghe
P
P
Lossos
A
A
Lynch
T
T
Mariotti
C
C
Schöls
L
L
Spinazzola
A
A
Szolnoki
Z
Z
Tabrizi
S J
SJ
Tallaksen
C M E
CM
Zeviani
M
M
Burgunder
J-M
JM
Harbo
H F
HF
D001259:Ataxia / Q000175:diagnosis* / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D010264:Paraplegia / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism; D015419:Spastic Paraplegia, Hereditary / Q000175:diagnosis* / Q000235:genetics* / Q000378:metabolism